Шрифт:
Закладка:
4320
Resnick SM, Matsumoto AM, Stephens-Shields AJ, et al. Testosterone treatment and cognitive function in older men with low testosterone and age-associated memory impairment. JAMA. 2017;317(7):717–27. https://pubmed.ncbi.nlm.nih.gov/28241356/
4321
Corona G, Guaraldi F, Rastrelli G, Sforza A, Maggi M. Testosterone deficiency and risk of cognitive disorders in aging males. World J Mens Health. 2021;39(1):9–18. https://pubmed.ncbi.nlm.nih.gov/32378366/
4322
Handelsman DJ. Testosterone and male aging: faltering hope for rejuvenation. JAMA. 2017;317(7):699–701. https://pubmed.ncbi.nlm.nih.gov/28241336/
4323
Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611–24. https://pubmed.ncbi.nlm.nih.gov/26886521/
4324
Diem SJ, Greer NL, MacDonald R, et al. Efficacy and safety of testosterone treatment in men: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med. 2020;172(2):105–18. https://pubmed.ncbi.nlm.nih.gov/31905375/
4325
Bandari J, Ayyash OM, Emery SL, Wessel CB, Davies BJ. Marketing and testosterone treatment in the USA: a systematic review. Eur Urol Focus. 2017;3(4–5):395–402. https://pubmed.ncbi.nlm.nih.gov/29174614/
4326
Huo S, Scialli AR, McGarvey S, et al. Treatment of men for “low testosterone”: a systematic review. PLoS One. 2016;11(9):e0162480. https://pubmed.ncbi.nlm.nih.gov/27655114/
4327
Snyder PJ, Kopperdahl DL, Stephens-Shields AJ, et al. Effect of testosterone treatment on volumetric bone density and strength in older men with low testosterone: a controlled clinical trial. JAMA Intern Med. 2017;177(4):471–9. https://pubmed.ncbi.nlm.nih.gov/28241231/
4328
Zhang Z, Kang D, Li H. The effects of testosterone on bone health in males with testosterone deficiency: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20(1):33. https://pubmed.ncbi.nlm.nih.gov/32145741/
4329
Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611–24. https://pubmed.ncbi.nlm.nih.gov/26886521/
4330
Huo S, Scialli AR, McGarvey S, et al. Treatment of men for “low testosterone”: a systematic review. PLoS One. 2016;11(9):e0162480. https://pubmed.ncbi.nlm.nih.gov/27655114/
4331
Maggi M, Filippi S, Vignozzi L, Rastrelli G. Controversial aspects of testosterone in the regulation of sexual function in late-onset hypogonadism. Andrology. 2020;8(6):1580–9. https://pubmed.ncbi.nlm.nih.gov/32248652/
4332
Corona G, Rastrelli G, Morgentaler A, Sforza A, Mannucci E, Maggi M. Meta-analysis of results of testosterone therapy on sexual function based on international index of erectile function scores. Eur Urol. 2017;72(6):1000–11. https://pubmed.ncbi.nlm.nih.gov/28434676/
4333
Maggi M, Filippi S, Vignozzi L, Rastrelli G. Controversial aspects of testosterone in the regulation of sexual function in late-onset hypogonadism. Andrology. 2020;8(6):1580–9. https://pubmed.ncbi.nlm.nih.gov/32248652/
4334
Kwan M, Greenleaf WJ, Mann J, Crapo L, Davidson JM. The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men. J Clin Endocrinol Metab. 1983;57(3):557–62. https://pubmed.ncbi.nlm.nih.gov/6874890/
4335
Maggi M, Filippi S, Vignozzi L, Rastrelli G. Controversial aspects of testosterone in the regulation of sexual function in late-onset hypogonadism. Andrology. 2020;8(6):1580–9. https://pubmed.ncbi.nlm.nih.gov/32248652/
4336
Adlin EV. Age-related low testosterone. Ann Intern Med. 2020;172(2):151–2. https://pubmed.ncbi.nlm.nih.gov/31905380/
4337
Lang PO, Samaras D, Samaras N. Testosterone replacement therapy in reversing “andropause”: what is the proof-of-principle? Rejuvenation Res. 2012;15(5):453–65. https://pubmed.ncbi.nlm.nih.gov/22656862/
4338
Corona G, Isidori AM, Buvat J, et al. Testosterone supplementation and sexual function: a meta-analysis study. J Sex Med. 2014;11(6):1577–92. https://pubmed.ncbi.nlm.nih.gov/24697970/
4339
Adlin EV. Age-related low testosterone. Ann Intern Med. 2020;172(2):151–2. https://pubmed.ncbi.nlm.nih.gov/31905380/
4340
Lang PO, Samaras D, Samaras N. Testosterone replacement therapy in reversing “andropause”: what is the proof-of-principle? Rejuvenation Res. 2012;15(5):453–65. https://pubmed.ncbi.nlm.nih.gov/22656862/
4341
Fisher AD, Corona G, Bandini E, et al. Psychobiological correlates of extramarital affairs and differences between stable and occasional infidelity among men with sexual dysfunctions. J Sex Med. 2009;6(3):866–75. https://pubmed.ncbi.nlm.nih.gov/19143911/
4342
Wagels L, Votinov M, Kellermann T, Eisert A, Beyer C, Habel U. Exogenous testosterone enhances the reactivity to social provocation in males. Front Behav Neurosci. 2018;12:37. https://pubmed.ncbi.nlm.nih.gov/29551966/
4343
Handelsman DJ. Pharmacoepidemiology of testosterone: impact of reimbursement policy on curbing off-label prescribing. Pharmacoepidemiol Drug Saf. 2020;29(9):1030–6. https://pubmed.ncbi.nlm.nih.gov/32743911/
4344
Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715–44. https://pubmed.ncbi.nlm.nih.gov/29562364/
4345
Shin YS, Park JK. The optimal indication for testosterone replacement therapy in late onset hypogonadism. J Clin Med. 2019;8(2):209. https://pubmed.ncbi.nlm.nih.gov/30736442/
4346
Roy CN, Snyder PJ, Stephens-Shields AJ, et al. Association of testosterone levels with anemia in older men: a controlled clinical trial. JAMA Intern Med. 2017;177(4):480–90. https://pubmed.ncbi.nlm.nih.gov/28241237/
4347
Swee DS, Gan EH. Late-onset hypogonadism as primary testicular failure. Front Endocrinol (Lausanne). 2019;10:372. https://pubmed.ncbi.nlm.nih.gov/31244778/
4348
Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363(2):109–22. https://pubmed.ncbi.nlm.nih.gov/20592293/
4349
Information update – possible cardiovascular problems associated with testosterone products. Government of Canada. https://recalls-rappels.canada.ca/en/alert-recall/information-update-possible-cardiovascular-problems-associated-testosterone-products. Published July 15, 2014. Accessed May 5, 2022.; https://recalls-rappels.canada.ca/en/alert-recall/information-update-possible-cardiovascular-problems-associated-testosterone-products
4350
Warren CJ, Wisener J, Ward B, et al. YouTube as a patient education resource for male hypogonadism and testosterone therapy. Sex Med. 2021;9(2):100324. https://pubmed.ncbi.nlm.nih.gov/33752104/
4351
Sansone A, Sansone M, Lenzi A, Romanelli F. Testosterone replacement therapy: the emperor’s new clothes. Rejuvenation Res. 2017;20(1):9–14. https://pubmed.ncbi.nlm.nih.gov/27124096/
4352
Warren CJ, Wisener J, Ward B, et al. YouTube as a patient education resource for male hypogonadism and testosterone therapy. Sex Med. 2021;9(2):100324. https://pubmed.ncbi.nlm.nih.gov/33752104/
4353
Huo S, Scialli AR, McGarvey
